US Patent Issued to ROCK BIOMEDICAL on Feb. 10 for "MGAT1 deficient cells and uses thereof" (American, Taiwanese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,941, issued on Feb. 10, was assigned to ROCK BIOMEDICAL INC. (Taipei, Taiwan).

"MGAT1 deficient cells and uses thereof" was invented by Chi-Huey Wong (Rancho Santa Fe, Calif.), Lan-Bo Chen (Woburn, Mass.), Ming-Wei Chen (Woburn, Mass.) and Jeng-Shin Lee (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for producing a modified cell deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase 1 ("MGAT1") activity. Also provided is a CHO cell line deficient in MGAT1 activity produced by the method. Further disclosed are methods for producing a glycoprotein."

The patent was filed on May 16, 2024, under...